BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31746087)

  • 1. Patient self-testing of white blood cell count and differentiation: A study of feasibility and measurement performance in a population of Danish cancer patients.
    Otto Mattsson T; Lindhart CL; Schöley J; Friis-Hansen L; Herrstedt J
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13189. PubMed ID: 31746087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care self-testing for measuring total white blood cells and C-reactive protein - a pilot study for future home-monitoring of patients during antibiotic treatment at home.
    Schousboe A; Wiese L
    Infect Dis (Lond); 2023 Apr; 55(4):235-242. PubMed ID: 36567452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the HemoCue WBC DIFF in leukopenic patient samples.
    Kur DK; Agersnap N; Holländer NH; Pedersen OBV; Friis-Hansen L
    Int J Lab Hematol; 2020 Jun; 42(3):256-262. PubMed ID: 32039560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive detection of severe neutropenia in chemotherapy patients by optical imaging of nailfold microcirculation.
    Bourquard A; Pablo-Trinidad A; Butterworth I; Sánchez-Ferro Á; Cerrato C; Humala K; Fabra Urdiola M; Del Rio C; Valles B; Tucker-Schwartz JM; Lee ES; Vakoc BJ; Padera TP; Ledesma-Carbayo MJ; Chen YB; Hochberg EP; Gray ML; Castro-González C
    Sci Rep; 2018 Mar; 8(1):5301. PubMed ID: 29593221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a point-of-care hematology analyzer for use in dogs and cats receiving chemotherapeutic treatment.
    Lara-Garcia A; Hosoya K; Iazbik C; Westendorf N; Gallant S; Couto G
    J Am Vet Med Assoc; 2008 May; 232(10):1488-95. PubMed ID: 18479238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary Results from a Prospective Study Comparing White Blood Cell and Neutrophil Counts from a Laboratory to Those Measured with a New Device in Patients with Breast Cancer.
    Lohman AC; VAN Rijn I; Lindhardt CL; Vonthein R; Rades D; Holländer NH
    In Vivo; 2018; 32(5):1283-1288. PubMed ID: 30150458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events.
    Demler TL; Morabito NE; Meyer CE; Opler L
    Int Clin Psychopharmacol; 2016 Mar; 31(2):76-83. PubMed ID: 26565383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutropenia: the accuracy and precision of the neutrophil count in leukopenic patients.
    Ross DW; McMaster K
    Cytometry; 1983 Jan; 3(4):287-91. PubMed ID: 6822148
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic value of perioperative leukocyte count in resectable gastric cancer.
    Chen XF; Qian J; Pei D; Zhou C; Røe OD; Zhu F; He SH; Qian YY; Zhou Y; Xu J; Xu J; Li X; Ping GQ; Liu YQ; Wang P; Guo RH; Shu YQ
    World J Gastroenterol; 2016 Mar; 22(9):2818-27. PubMed ID: 26973420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a new point-of-care testing system for measuring white blood cell and C-reactive protein levels in whole blood samples.
    Kotani K; Minami T; Abe T; Sato J; Taniguchi N; Yamada T
    Clin Chim Acta; 2014 Jun; 433():145-9. PubMed ID: 24642344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.
    Choi CW; Sung HJ; Park KH; Yoon SY; Kim SJ; Oh SC; Seo JH; Kim BS; Shin SW; Kim YH; Kim JS
    Am J Hematol; 2003 Aug; 73(4):263-6. PubMed ID: 12879430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting 30-day mortality using point-of-care testing; an external validation and derivation study.
    Brink A; Schuttevaer R; Alsma J; Zietse R; Schuit SCE; Lingsma HF
    PLoS One; 2020; 15(9):e0239318. PubMed ID: 32970708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy and feasibility of point-of-care white blood cell count and C-reactive protein measurements at the pediatric emergency department.
    Ivaska L; Niemelä J; Leino P; Mertsola J; Peltola V
    PLoS One; 2015; 10(6):e0129920. PubMed ID: 26034987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting the white blood cell count in the cancer chemotherapy patient. Nursing responsibilities.
    Highes CB
    NITA; 1985; 8(4):279-82. PubMed ID: 3852081
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department.
    Kankaanpää M; Raitakari M; Muukkonen L; Gustafsson S; Heitto M; Palomäki A; Suojanen K; Harjola VP
    Scand J Trauma Resusc Emerg Med; 2016 Oct; 24(1):125. PubMed ID: 27756354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relevance of a simultaneous measurement of WBC and CRP as a POCT(point of care testing) of the inflammatory markers running title: the POCT(point of care testing) of WBC and CRP].
    Miyazaki M
    Rinsho Byori; 2002 Nov; 50(11):1029-34. PubMed ID: 12491598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring health-related quality of life and neutropenia-specific concerns among older adults undergoing chemotherapy: validation of the Functional Assessment of Cancer Therapy-Neutropenia (FACT-N).
    Wagner LI; Beaumont JL; Ding B; Malin J; Peterman A; Calhoun E; Cella D
    Support Care Cancer; 2008 Jan; 16(1):47-56. PubMed ID: 17619911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction.
    Smith A; Couvillion R; Zhang R; Killackey M; Buell J; Lee B; Saggi BH; Paramesh AS
    Transplant Proc; 2014 Dec; 46(10):3400-4. PubMed ID: 25498059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the feasibility and acceptability of an oral care diary by patients during chemotherapy.
    Miller M; Taylor A; Kearney N; Paterson G; Wells M; Roe L; Hagen S; Maguire R
    Int J Nurs Stud; 2007 Jul; 44(5):693-701. PubMed ID: 16545385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
    Maher DW; Lieschke GJ; Green M; Bishop J; Stuart-Harris R; Wolf M; Sheridan WP; Kefford RF; Cebon J; Olver I; McKendrick J; Toner G; Bradstock K; Lieschke M; Cruickshank S; Tomita DK; Hoffman EW; Fox RM; Morstyn G
    Ann Intern Med; 1994 Oct; 121(7):492-501. PubMed ID: 7520676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.